Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-05

Clinical Trial Update: Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial update evaluating Stem Cell Educator Therapy for reversing type 1 diabetes in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stem Cell Educator Therapy

Snippet

Sponsor: Throne Biotechnologies Inc. | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: UNKNOWN